Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 12/2003

01-12-2003 | Concise Article

Role of Chlamydia pneumoniae and Mycoplasma pneumoniae as Causative Agents of Community-Acquired Pneumonia in Hospitalised Children and Adolescents

Authors: G. Baer, G. Engelcke, M. Abele-Horn, U. B. Schaad, U. Heininger

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 12/2003

Login to get access

Abstract

The aim of the study presented here was to determine the prevalence of Chlamydia pneumoniae versus Mycoplasma pneumoniae infections in paediatric patients with community-acquired pneumonia. A total of 50 patients (mean age, 5.5 years; median, 3.9 years) with community-acquired pneumonia were enrolled. Four patients were found to have Chlamydia pneumoniae infection (1 culture positive, 1 PCR positive and 2 serology positive) and 16 patients had Mycoplasma pneumoniae infection (2 PCR positive, 4 PCR and serology positive, 10 serology positive), including three patients with coinfection. The rates of Mycoplasma pneumoniae infection were 22%, 35% and 40% in children aged 1–3, >3–7 and >7 years, respectively. Acute Chlamydia pneumoniae infection was substantially less common than Mycoplasma pneumoniae infection in our study cohort.
Literature
1.
go back to reference Normann E, Gnarpe J, Gnarpe H, Wettergren B (1998) Chlamydia pneumoniae in children attending day-care centers in Gavle, Sweden. Pediatr Infect Dis J 17:474–478CrossRefPubMed Normann E, Gnarpe J, Gnarpe H, Wettergren B (1998) Chlamydia pneumoniae in children attending day-care centers in Gavle, Sweden. Pediatr Infect Dis J 17:474–478CrossRefPubMed
2.
go back to reference Schmidt SM, Müller CE, Mahner B, Wiersbitzky SKW (2002) Prevalence, rate of persistence and respiratory tract symptoms of Chlamydia pneumoniae infection in 1211 kindergarten and school age children. Pediatr Infect Dis J 21:758–762CrossRefPubMed Schmidt SM, Müller CE, Mahner B, Wiersbitzky SKW (2002) Prevalence, rate of persistence and respiratory tract symptoms of Chlamydia pneumoniae infection in 1211 kindergarten and school age children. Pediatr Infect Dis J 21:758–762CrossRefPubMed
3.
go back to reference Block S, Hedrick J, Hammerschlag MR, Cassel GH, Craft JC (1995) Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J 14:471–477PubMed Block S, Hedrick J, Hammerschlag MR, Cassel GH, Craft JC (1995) Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J 14:471–477PubMed
4.
go back to reference Wubbel L, Muniz L, Ahmed A, Trujillo M, Carubelli C, McCoig C, Abramo T, Leinonen M, McCracken GH (1999) Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J 18:98–104CrossRefPubMed Wubbel L, Muniz L, Ahmed A, Trujillo M, Carubelli C, McCoig C, Abramo T, Leinonen M, McCracken GH (1999) Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J 18:98–104CrossRefPubMed
5.
go back to reference Harris JA, Kolokathis A, Campbell M, Cassell GH, Hammerschlag MR (1998) Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. Pediatr Infect Dis J 17:865–871CrossRefPubMed Harris JA, Kolokathis A, Campbell M, Cassell GH, Hammerschlag MR (1998) Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. Pediatr Infect Dis J 17:865–871CrossRefPubMed
6.
go back to reference Principi N, Esposito S, Blasi F, Allegra L, and the Mowgli Study Group (2001) Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. Clin Infect Dis 32:1281–1289CrossRefPubMed Principi N, Esposito S, Blasi F, Allegra L, and the Mowgli Study Group (2001) Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. Clin Infect Dis 32:1281–1289CrossRefPubMed
7.
go back to reference Normann E, Gnarpe J, Gnarpe H, Wettergren B (1998) Chlamydia pneumoniae in children with acute respiratory tract infections. Acta Paediatr 87:23–27CrossRefPubMed Normann E, Gnarpe J, Gnarpe H, Wettergren B (1998) Chlamydia pneumoniae in children with acute respiratory tract infections. Acta Paediatr 87:23–27CrossRefPubMed
8.
go back to reference World Health Organisation (1994) Program for control of acute respiratory infections. WHO/ARI/94.33 World Health Organisation (1994) Program for control of acute respiratory infections. WHO/ARI/94.33
9.
go back to reference Campbell LA, Perez Melgosa M, Hamilton DJ, Kuo CC, Grayston JT (1992) Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol 30:434–439PubMed Campbell LA, Perez Melgosa M, Hamilton DJ, Kuo CC, Grayston JT (1992) Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol 30:434–439PubMed
10.
go back to reference Ieven M, Ursi D, Van Bever H, Quint W, Niesters HGM, Goossens H (1996) Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients. J Infect Dis 173:1445–1452PubMed Ieven M, Ursi D, Van Bever H, Quint W, Niesters HGM, Goossens H (1996) Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients. J Infect Dis 173:1445–1452PubMed
11.
go back to reference Roblin PM, Dumornay W, Hammerschlag MR (1992) Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol 30:1968–1971PubMed Roblin PM, Dumornay W, Hammerschlag MR (1992) Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol 30:1968–1971PubMed
12.
go back to reference Waris ME, Toikka P, Saarinen T, Nikkari S, Meurman O, Vainionpää R, Mertsola J, Ruuskanen O (1998) Diagnosis of Mycoplasma pneumoniae pneumonia in children. J Clin Microbiol 36:3155–3159PubMed Waris ME, Toikka P, Saarinen T, Nikkari S, Meurman O, Vainionpää R, Mertsola J, Ruuskanen O (1998) Diagnosis of Mycoplasma pneumoniae pneumonia in children. J Clin Microbiol 36:3155–3159PubMed
13.
go back to reference Apfalter P, Barousch W, Nehr M, Makristathis A, Willinger B, Rotter M, Hirschl AM (2003) Comparison of a new quantitative ompA-based real-time PCR TaqMan assay for detection of Chlamydia pneumoniae DNA in respiratory specimens with four conventional PCR assays. J Clin Microbiol 41:592–600CrossRefPubMed Apfalter P, Barousch W, Nehr M, Makristathis A, Willinger B, Rotter M, Hirschl AM (2003) Comparison of a new quantitative ompA-based real-time PCR TaqMan assay for detection of Chlamydia pneumoniae DNA in respiratory specimens with four conventional PCR assays. J Clin Microbiol 41:592–600CrossRefPubMed
14.
go back to reference Grayston JT, Campbell LA, Kuo CC, Mordhorst CH, Saikku P, Thom DH, Wang SP (1990) A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 161:618–625PubMed Grayston JT, Campbell LA, Kuo CC, Mordhorst CH, Saikku P, Thom DH, Wang SP (1990) A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 161:618–625PubMed
Metadata
Title
Role of Chlamydia pneumoniae and Mycoplasma pneumoniae as Causative Agents of Community-Acquired Pneumonia in Hospitalised Children and Adolescents
Authors
G. Baer
G. Engelcke
M. Abele-Horn
U. B. Schaad
U. Heininger
Publication date
01-12-2003
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 12/2003
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-003-1037-9

Other articles of this Issue 12/2003

European Journal of Clinical Microbiology & Infectious Diseases 12/2003 Go to the issue

Announcements

December 2003

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.